Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment

Pediatric adrenocortical tumors (ACTs) are rare and heterogeneous. Approximately 50% of children with ACT carry a germline TP53 variant; however, the genetic underpinning of remaining cases has not been elucidated. In patients having germline TP53 variants, loss of maternal chromosome 11 and duplica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emilia Modolo Pinto, Carlos Rodriguez-Galindo, Catherine G. Lam, Robert E. Ruiz, Gerard P. Zambetti, Raul C. Ribeiro
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
UPD
Acceso en línea:https://doaj.org/article/b185a85e41364ff1b358316a95e9282a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b185a85e41364ff1b358316a95e9282a
record_format dspace
spelling oai:doaj.org-article:b185a85e41364ff1b358316a95e9282a2021-11-05T14:52:02ZAdrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment1664-239210.3389/fendo.2021.756523https://doaj.org/article/b185a85e41364ff1b358316a95e9282a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fendo.2021.756523/fullhttps://doaj.org/toc/1664-2392Pediatric adrenocortical tumors (ACTs) are rare and heterogeneous. Approximately 50% of children with ACT carry a germline TP53 variant; however, the genetic underpinning of remaining cases has not been elucidated. In patients having germline TP53 variants, loss of maternal chromosome 11 and duplication of the paternal copy [paternal uniparental disomy, (UPD)] occurs early in tumorigenesis and explains the overexpression of IGF2, the hallmark of pediatric ACT. Beckwith-Wiedemann syndrome (BWS) is also associated with overexpression of IGF2 due to disruption of the 11p15 loci, including segmental UPD. Here, we report six children with ACT with wild type TP53 and germline paternal 11p15 UPD. Median age of five girls and one boy was 3.2 years (range 0.5-11 years). Two patients met the criteria for BWS before diagnosis of ACT. However, ACT was the first and only manifestation of paternal 11p15 UPD in four children. Tumor weight ranged from 21.5 g to 550 g. Despite poor prognostic features at presentation, such as pulmonary metastasis, bilateral adrenal involvement, and large tumors, all patients are alive 8-21 years after cancer diagnosis. Our observations suggest that children with ACT and wild type TP53, irrespective of their age, should be screened for germline abnormalities in chromosome 11p15.Emilia Modolo PintoCarlos Rodriguez-GalindoCarlos Rodriguez-GalindoCatherine G. LamCatherine G. LamRobert E. RuizGerard P. ZambettiRaul C. RibeiroFrontiers Media S.A.articleBeckwith-Wiedemann syndromeadrenocortical cancerhemihypertrophiachromosome 11p15TP53UPDDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENFrontiers in Endocrinology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Beckwith-Wiedemann syndrome
adrenocortical cancer
hemihypertrophia
chromosome 11p15
TP53
UPD
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle Beckwith-Wiedemann syndrome
adrenocortical cancer
hemihypertrophia
chromosome 11p15
TP53
UPD
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Emilia Modolo Pinto
Carlos Rodriguez-Galindo
Carlos Rodriguez-Galindo
Catherine G. Lam
Catherine G. Lam
Robert E. Ruiz
Gerard P. Zambetti
Raul C. Ribeiro
Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment
description Pediatric adrenocortical tumors (ACTs) are rare and heterogeneous. Approximately 50% of children with ACT carry a germline TP53 variant; however, the genetic underpinning of remaining cases has not been elucidated. In patients having germline TP53 variants, loss of maternal chromosome 11 and duplication of the paternal copy [paternal uniparental disomy, (UPD)] occurs early in tumorigenesis and explains the overexpression of IGF2, the hallmark of pediatric ACT. Beckwith-Wiedemann syndrome (BWS) is also associated with overexpression of IGF2 due to disruption of the 11p15 loci, including segmental UPD. Here, we report six children with ACT with wild type TP53 and germline paternal 11p15 UPD. Median age of five girls and one boy was 3.2 years (range 0.5-11 years). Two patients met the criteria for BWS before diagnosis of ACT. However, ACT was the first and only manifestation of paternal 11p15 UPD in four children. Tumor weight ranged from 21.5 g to 550 g. Despite poor prognostic features at presentation, such as pulmonary metastasis, bilateral adrenal involvement, and large tumors, all patients are alive 8-21 years after cancer diagnosis. Our observations suggest that children with ACT and wild type TP53, irrespective of their age, should be screened for germline abnormalities in chromosome 11p15.
format article
author Emilia Modolo Pinto
Carlos Rodriguez-Galindo
Carlos Rodriguez-Galindo
Catherine G. Lam
Catherine G. Lam
Robert E. Ruiz
Gerard P. Zambetti
Raul C. Ribeiro
author_facet Emilia Modolo Pinto
Carlos Rodriguez-Galindo
Carlos Rodriguez-Galindo
Catherine G. Lam
Catherine G. Lam
Robert E. Ruiz
Gerard P. Zambetti
Raul C. Ribeiro
author_sort Emilia Modolo Pinto
title Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment
title_short Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment
title_full Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment
title_fullStr Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment
title_full_unstemmed Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment
title_sort adrenocortical tumors in children with constitutive chromosome 11p15 paternal uniparental disomy: implications for diagnosis and treatment
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/b185a85e41364ff1b358316a95e9282a
work_keys_str_mv AT emiliamodolopinto adrenocorticaltumorsinchildrenwithconstitutivechromosome11p15paternaluniparentaldisomyimplicationsfordiagnosisandtreatment
AT carlosrodriguezgalindo adrenocorticaltumorsinchildrenwithconstitutivechromosome11p15paternaluniparentaldisomyimplicationsfordiagnosisandtreatment
AT carlosrodriguezgalindo adrenocorticaltumorsinchildrenwithconstitutivechromosome11p15paternaluniparentaldisomyimplicationsfordiagnosisandtreatment
AT catherineglam adrenocorticaltumorsinchildrenwithconstitutivechromosome11p15paternaluniparentaldisomyimplicationsfordiagnosisandtreatment
AT catherineglam adrenocorticaltumorsinchildrenwithconstitutivechromosome11p15paternaluniparentaldisomyimplicationsfordiagnosisandtreatment
AT roberteruiz adrenocorticaltumorsinchildrenwithconstitutivechromosome11p15paternaluniparentaldisomyimplicationsfordiagnosisandtreatment
AT gerardpzambetti adrenocorticaltumorsinchildrenwithconstitutivechromosome11p15paternaluniparentaldisomyimplicationsfordiagnosisandtreatment
AT raulcribeiro adrenocorticaltumorsinchildrenwithconstitutivechromosome11p15paternaluniparentaldisomyimplicationsfordiagnosisandtreatment
_version_ 1718444250502266880